Cardinal Health, Inc. $CAH Shares Acquired by Inceptionr LLC

Inceptionr LLC boosted its holdings in Cardinal Health, Inc. (NYSE:CAH) by 155.9% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,851 shares of the company’s stock after purchasing an additional 6,002 shares during the quarter. Cardinal Health makes up about 0.5% of Inceptionr LLC’s investment portfolio, making the stock its 12th largest holding. Inceptionr LLC’s holdings in Cardinal Health were worth $2,077,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. University of Texas Texas AM Investment Management Co. bought a new stake in Cardinal Health during the 4th quarter valued at $26,000. Bank of Jackson Hole Trust acquired a new stake in Cardinal Health during the fourth quarter valued at approximately $27,000. Jones Financial Companies Lllp boosted its stake in shares of Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after acquiring an additional 14,034 shares in the last quarter. Palladiem LLC purchased a new position in Cardinal Health in the 4th quarter worth about $28,000. Finally, Indiana Trust & Investment Management Co acquired a new stake in shares of Cardinal Health during the first quarter valued at approximately $29,000. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Trading Up 2.3%

Shares of CAH opened at $225.54 on Friday. The stock has a market capitalization of $52.82 billion, a price-to-earnings ratio of 34.49, a PEG ratio of 1.08 and a beta of 0.49. Cardinal Health, Inc. has a 12 month low of $137.75 and a 12 month high of $243.21. The firm has a fifty day simple moving average of $219.32 and a 200 day simple moving average of $214.34.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. The firm had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business’s revenue was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, research analysts predict that Cardinal Health, Inc. will post 10.77 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st were paid a $0.5158 dividend. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend was Wednesday, July 1st. Cardinal Health’s payout ratio is 31.50%.

Analysts Set New Price Targets

A number of research analysts recently commented on the stock. Citigroup reaffirmed a “buy” rating on shares of Cardinal Health in a research report on Thursday, July 2nd. Weiss Ratings downgraded shares of Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a report on Tuesday, May 19th. Bank of America increased their price objective on Cardinal Health from $240.00 to $260.00 and gave the company a “buy” rating in a research report on Thursday, July 2nd. Wall Street Zen upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, July 4th. Finally, Robert W. Baird set a $248.00 target price on shares of Cardinal Health in a research note on Friday, May 1st. Fifteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, Cardinal Health currently has an average rating of “Moderate Buy” and an average target price of $250.40.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.